Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
J
420570
vs
K
KOSPI 200
Over the past 12 months, J2KBio Co Ltd has underperformed KOSPI 200, delivering a return of +0% compared to KOSPI 200's +125% growth.
Stocks Performance
420570 vs KOSPI 200
Performance Gap
420570 vs KOSPI 200
Performance By Year
420570 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
J2KBio Co Ltd
Glance View
J2KBio Co Ltd makes life science and diagnostic products used in labs and medical testing. Its core products are research reagents, antibodies, proteins, and test kits that help scientists study diseases and help labs detect specific biological markers. The company sits in the middle of the healthcare supply chain: it turns biological materials into standardized products that other companies, hospitals, and research labs can use. Its customers are mainly pharmaceutical and biotech firms, academic and clinical laboratories, and distributors that resell lab products. J2KBio earns money by selling these reagents and kits, and in some cases by supplying custom or contract-manufactured materials for other companies. That means its business depends on repeat purchases of consumable products rather than one-time equipment sales. What makes the business model different is that demand comes from both research and diagnostics. Research customers use its products to run experiments, while diagnostic customers use them in testing workflows that need reliable, consistent raw materials. That gives J2KBio a role as a specialized supplier of the building blocks that make many lab tests and biotech projects possible.